Bioavailability Is Not the Same as Better Health

What Does That Even Mean? · Article 7 of 8
← Article 6 · Series index · Article 8 →

“Bioavailable” sounds like a destination has been reached. The nutrient is available to the body; therefore the product must work better.

Absorption matters. A compound that never becomes available at the relevant biological site cannot produce the intended systemic effect. Formulation, food, digestive conditions, chemical form, interactions, dose, and timing can all influence how much of a substance reaches circulation or tissue.

But bioavailability is one link in a chain, not the final outcome.

More absorbed is not always more beneficial

A product can increase blood levels of a nutrient without improving how a person feels or functions. The body may already have adequate status. The measured increase may remain within a range that does not change the health outcome. Homeostatic systems may regulate storage, conversion, use, and excretion. The marker may be related to the outcome without being a reliable substitute for it.

The distinction is familiar in drug and nutrition research: pharmacokinetic or biomarker changes can show that something entered the body or altered a pathway, but clinical benefit requires evidence about symptoms, disease events, function, quality of life, or another meaningful endpoint.

This is particularly important when an advertisement gives a relative number: “2.7 times more bioavailable,” for example. A large relative difference can describe a small absolute change. The comparison form may be unusually poorly absorbed. The test may use a single dose under controlled conditions that does not reflect long-term use. And even a genuine increase in absorption may provide no added benefit if the lower amount was already sufficient.

Bioavailability is specific, not a personality trait

Products often use “bioavailable” as a general quality adjective, as though the entire bottle possesses superior biological intelligence. In reality, bioavailability is specific to a substance, form, dose, route, measurement, and context.

Ritual, for example, explains its selection of particular nutrient forms in terms of absorption and cites clinical research on forms and on some finished products. That is more informative than using the word alone. The remaining consumer task is to distinguish evidence of delivery from evidence of benefit and to determine whether the claimed advantage matters for the intended population.

A nutrient form can be a rational formulation choice without making the product clinically superior. Conversely, a product does not need the most absorbable possible form if a less expensive form reliably achieves adequate status and outcomes.

Surrogate endpoints compress the sales story

Bioavailability marketing works because it shortens a long causal chain:

The product is consumed. The ingredient survives digestion. It is absorbed. It reaches the relevant tissue. It changes a biological process. That change improves an outcome. The improvement is large enough to matter. The benefits outweigh costs and risks.

An absorption study may support the second or third link. Advertising often allows the consumer to assume the rest.

This does not make absorption data worthless. It makes the boundary of the evidence important. Good science says where the evidence ends.

Ask what happened after absorption

When “bioavailable” appears in an advertisement, identify the comparison. Which form was tested? In what population? Was the study a single-dose pharmacokinetic experiment or a longer clinical trial? Did it measure blood concentration, nutrient status, symptoms, function, or health events? Was the finished product tested, or only the ingredient form?

The better question is: What meaningful outcome improved because more of this substance became available?

Sources

• Ritual. “What Is Bioavailability? Here’s Why It’s So Important.” https://ritual.com/blogs/science/bioavailability
• National Institutes of Health, Office of Dietary Supplements. “Dietary Supplements: What You Need to Know.” https://ods.od.nih.gov/factsheets/WYNTK-Consumer/
• Federal Trade Commission. Health Products Compliance Guidance. 2022. https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance

Continue the investigation: Series index · Article 8 →

Related reading

Educational information only. This article is not a diagnosis or individualized medical or nutrition treatment. New, severe, persistent, or concerning symptoms should be evaluated by an appropriate healthcare professional.